Neuron- and glia-like cells derived from induced pluripotent stem cells promise tractable, individualized human models of Alzheimer's, Parkinson's and amyotrophic lateral sclerosis. Ken Garber explores the considerable challenges of recreating such diseases in the laboratory.
